Treatment-Related Toxicity in Advanced Medullary Thyroid Cancer

0 Views
administrator
administrator
07/06/23

Not all patients with advanced medullary thyroid cancer are candidates for vandetanib and cabozantinib, due to treatment-related toxicity. As a result, in this segment, the panelists describe which patients should receive aggressive treatment.

For more from the discussion, visit http://www.onclive.com/peer-exchange/managing-mtc

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next